President signed the corresponding law
The Institute of Nuclear Physics in Almaty accounts for 90% of all radiopharmaceuticals produced in Kazakhstan
The healthcare ministry has agreed to localize production of the PREVNAR 20 vaccine
AstraZeneca considers the possibility of localizing production in the country
The production of the first batch is expected by the end of 2023
The plant construction will lead to the creation of 170 jobs in the region
Atabay will produce various drugs in Kazakhstan, and Nobel Ilac to focus on oncology medicine
